Data on duration of medication use, adherence, discontinuation and concomitant medications cannot be captured from prescriptions databases, and dosing data for liraglutide and dulaglutide were unavailable or incomplete, so it was not possible to determine whether patients were optimized on their baseline GLP-1 RA
In this study, we define the weight-loss plateau as the stage at which the efficacy of further body weight and fat reduction attenuates despite continued therapy [11, 12], and we emphasize the clinical need for novel approaches capable of complementing GLP-1 RAs to achieve normal body composition [10, 13]
Often, the current medications do not help with fat burning but rather focus on appetite management
Retrieved from Baranwal, N., Yu, P
Enhance with a light amount of Two Timing Tightener (DMAE Serum) on top for improved results